D-dimer testing and recurrent venous thromboembolism after unprovoked pulmonary embolism: A post-hoc analysis of the prolong extension study

Vittorio Pengo; Gualtiero Palareti; Benilde Cosmi; Cristina Legnani; Alberto Tosetto; Adriano Alatri; Filippo Marzot; Cinzia Pegoraro; Umberto Cucchini; Sabino Iliceto; for the PROLONG Investigators (on behalf of FCSA, Italian Federation of Anticoagulation Clinics)

doi:10.1160/TH08-04-0250

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2008; 100(04): 718-721
DOI: 10.1160/TH08-04-0250

Letters to the Editor

Schattauer GmbH

D-dimer testing and recurrent venous thromboembolism after unprovoked pulmonary embolism: A post-hoc analysis of the prolong extension study

Vittorio Pengo

¹Department of Cardiac, Thoracic and Vascular Sciences, Clinical Cardiology, University Hospital, Padua, Italy

,

Gualtiero Palareti

²Department of Angiology & Blood Coagulation “Marino Golinelli”, University Hospital S. Orsola-Malpighi, Bologna, Italy

,

Benilde Cosmi

²Department of Angiology & Blood Coagulation “Marino Golinelli”, University Hospital S. Orsola-Malpighi, Bologna, Italy

,

Cristina Legnani

²Department of Angiology & Blood Coagulation “Marino Golinelli”, University Hospital S. Orsola-Malpighi, Bologna, Italy

,

Alberto Tosetto

³Department of Hematology, S. Bortolo Hospital, Vicenza, Italy

,

Adriano Alatri

⁴Haemostasis & Thrombosis Center, General Hospital, Cremona, Italy

,

Filippo Marzot

¹Department of Cardiac, Thoracic and Vascular Sciences, Clinical Cardiology, University Hospital, Padua, Italy

,

Cinzia Pegoraro

¹Department of Cardiac, Thoracic and Vascular Sciences, Clinical Cardiology, University Hospital, Padua, Italy

,

Umberto Cucchini

¹Department of Cardiac, Thoracic and Vascular Sciences, Clinical Cardiology, University Hospital, Padua, Italy

,

Sabino Iliceto

¹Department of Cardiac, Thoracic and Vascular Sciences, Clinical Cardiology, University Hospital, Padua, Italy

,

for the PROLONG Investigators (on behalf of FCSA, Italian Federation of Anticoagulation Clinics)

› Author Affiliations

Abstract

Full Text

References

References
1 Buller HR, Agnelli G, Hull RD. et al. Antithrombotic therapy for venous thromboembolic disease. The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126: 401S-428S.
2 Prandoni P, Lensing AW, Prins MH. et al. Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism. Ann Intern Med 2002; 137: 955-960.
3 Piovella F, Crippa L, Barone M. et al. Normalization rates of compression ultrasonography in patients with a first episode of deep vein thrombosis of the lower limbs: association with recurrence and new thrombosis. Haematologica 2002; 87: 515-522.
4 Palareti G, Legnani C, Cosmi B. et al. Risk of venous thromboembolism recurrence: high negative predictive value of D-dimer performed after oral anti-coagulation is stopped. Thromb Haemost 2002; 87: 7-12.
5 Palareti G, Legnani C, Cosmi B. et al. Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia. Circulation 2003; 108: 313-318.
6 Eichinger S, Minar E, Bialonczyk C. et al. D-dimer levels and risk of recurrent venous thromboembolism. J Am Med Assoc 2003; 290: 1071-1074.
7 Palareti G, Cosmi B, Legnani C. et al. D-dimer testing to determine the duration of anticoagulation Therapy. N Engl J Med 2006; 355: 1780-1789.
8 Palareti G, Leali N, Coccheri S. et al. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (IS-COAT ): Italian Study on Complications of Oral Anticoagulant Therapy. Lancet 1996; 348: 423-428.
9 Agnelli G, Prandoni P, Becattini C. et al. for the WODIT investigators: Extended oral anticoagulant therapy after a first episode of pulmonary embolism. Ann Intern Med 2003; 139: 19-25.
10 Eichinger S, Weltermann A, Minar E. et al. Symptomatic pulmonary embolism and the risk of recurrent venousthromboembolism. Arch Intern Med 2004; 164: 92-96.
11 Pengo V, Lensing AW, Prins MH. et al. for the Thromboembolic pulmonary hypertension study group: Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med 2004; 350: 2257-2264.
12 Murin S, Romano PS, White RH. Comparison of outcomes after hospitalization for deep venous thrombosis or pulmonary embolism. Thromb Haemost 2002; 88: 407-414.
13 Kearon C, Gent M, Hirsh J. et al. A comparison of three months of anticoagulation with extended anti-coagulation for a first episode of idiopathic venous thromboembolism. N Engl J Med 1999; 340: 901-907.
14 Douketis JD, Kearon C, Bates S. et al. Risk of fatal pulmonary embolism in patients with treated venous thromboembolism. J Am Med Assoc 1998; 279: 458-462.
15 Agnelli G, Prandoni P, Santamaria MG. et al. for the Wodit investigators: Three months versus one year of oral anticoagulant therapy for idiopathic deep vein thrombosis. N Engl J Med 2001; 345: 165-169.